Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study

Olmos, D. et al. (2012) Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study. Lancet Oncology, 13(11), pp. 1114-1124. (doi:10.1016/S1470-2045(12)70372-8)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Jones, Professor Robert
Authors: Olmos, D., Brewer, D., Clark, J., Danila, D.C., Parker, C., Attard, G., Fleisher, M., Reid, A.H.M., Castro, E., Sandhu, S.K., Barwell, L., Oommen, N.B., Carreira, S., Drake, C.G., Jones, R.J., Cooper, C.S., Scher, H.I., and deBono, J.S.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Lancet Oncology
ISSN:1470-2045

University Staff: Request a correction | Enlighten Editors: Update this record